| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based Regimens
|
Waliany, Sarah
|
|
|
23 |
6 |
p. 498-509
|
artikel
|
| 2 |
Clinical-Molecular Prospective Cohort Study in Non-Small Cell Lung Cancer (PROMOLE study): A Comprehensive Approach to Identify New Predictive Markers of Pharmacological Response
|
Bironzo, Paolo
|
|
|
23 |
6 |
p. e347-e352
|
artikel
|
| 3 |
Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer
|
Riudavets, Mariona
|
|
|
23 |
6 |
p. e377-e383
|
artikel
|
| 4 |
Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients
|
Shimoda, Yukiko
|
|
|
23 |
6 |
p. 477-486
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
23 |
6 |
p. A1
|
artikel
|
| 6 |
Extended Delay to Treatment for Stage III-IV Non–Small-Cell Lung Cancer and Survival: Balancing Risks During the COVID-19 Pandemic
|
Mayne, Nicholas R.
|
|
|
23 |
6 |
p. e362-e376
|
artikel
|
| 7 |
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival
|
Cucchiara, Federico
|
|
|
23 |
6 |
p. 510-521
|
artikel
|
| 8 |
Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings
|
Yoneda, Taro
|
|
|
23 |
6 |
p. 467-476
|
artikel
|
| 9 |
Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)
|
Cardona, Andrés F.
|
|
|
23 |
6 |
p. 522-531
|
artikel
|
| 10 |
Pembrolizumab-Associated Cutaneous and Pulmonary Sarcoidosis in Non–Small Cell Lung Cancer Treatment
|
Sirgi, Yasmina
|
|
|
23 |
6 |
p. 542-546
|
artikel
|
| 11 |
Rationale and Design of the Phase III KEYLYNK-012 Study of Pembrolizumab and Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Stage III Non-Small-Cell Lung Cancer
|
Jabbour, Salma K.
|
|
|
23 |
6 |
p. e342-e346
|
artikel
|
| 12 |
Real-world clinical practice for advanced non-small-cell lung cancer in the very elderly: A retrospective multicenter analysis
|
Fukushima, Takahiro
|
|
|
23 |
6 |
p. 532-541
|
artikel
|
| 13 |
Safety and Efficacy of Epitinib for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases: Open-Label Multicentre Dose-Expansion Phase Ib Study
|
Zhou, Qing
|
|
|
23 |
6 |
p. e353-e361
|
artikel
|
| 14 |
Successful Use of Sotorasib in a Patient With End-Stage Renal Disease on Dialysis With Metastatic Lung Adenocarcinoma: A Case Report
|
Sproat, Michelle R.
|
|
|
23 |
6 |
p. e339-e341
|
artikel
|
| 15 |
Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic Database
|
Wu, Yanyu
|
|
|
23 |
6 |
p. 487-497
|
artikel
|
| 16 |
Table of Contents
|
|
|
|
23 |
6 |
p. A3-A5
|
artikel
|
| 17 |
The Significance of Lymph Node Ratio and Total Lymph Nodes Examined in Determining the Indications of Adjuvant Radiation in pN2 Non–small Cell Lung Cancer
|
Zhu, Fan
|
|
|
23 |
6 |
p. e384-e393
|
artikel
|
| 18 |
Treatment Considerations for Patients With Advanced Squamous Cell Carcinoma of the Lung
|
Santos, Edgardo S.
|
|
|
23 |
6 |
p. 457-466
|
artikel
|
Tijdschrift beschrijving